The Year in Cardiac Imaging  by Gibbons, Raymond J. et al.
T
t
s
i
c
r
r
E
A
c
d
d
o
p
s
t
t
T
N
o
i
c
i
p
fl
P
c
m
i
p
p
t
w
a
F
M
R
P
t
a
f
Journal of the American College of Cardiology Vol. 53, No. 1, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
PYEAR IN CARDIOLOGY SERIES
The Year in Cardiac Imaging
Raymond J. Gibbons, MD,* Philip A. Araoz, MD,† Eric E. Williamson, MD†
Rochester, Minnesota
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.09.024C
R
2
o
s
i
o
(
p
i
J
a
d
M
m
d
p
M
t
a
t
V
P
p
s
P
P
F
w
t
i
y
w
F
o
o
o
c
dhis review is a sequel to our 3 previous reports highlighting
he most important recent literature in single-photon emis-
ion computed tomography (SPECT), myocardial perfusion
maging, cardiac positron emission tomography (PET),
ardiac computed tomography (CT), and cardiac magnetic
esonance imaging (MRI). In contrast to our previous
eports, which covered 1 year each, this report covers the
nglish-language literature over a 15-month period from
pril 1, 2007, to June 30, 2008. The increased length of our
overage period has magnified the difficulty of reaching a
ecision as to which articles merit inclusion. Our previous
ecisions have pleased some authors and disappointed
thers. We have again made every effort to avoid our
ersonal biases in reaching these ever more difficult deci-
ions. Our summary is once again organized around topical
hemes, reflecting the growing interest in integrated, mul-
imodality imaging to solve clinical problems.
echnical Advances
ovel imaging approaches. Amid the technical advances
f SPECT, PET, CT, and MRI, work continues on novel
maging approaches. Detter et al. (1) validated fluorescent
ardiac imaging using a novel, indocyanine green–based
maging system in a porcine model; impaired myocardial
erfusion assessed by this technique correlated well with
uorescent microspheres.
ET. The potential application of vascular fluorodeoxyglu-
ose (FDG)-PET imaging to coronary arteries is limited by
yocardial FDG uptake. Williams and Kolodny (2) exam-
ned the effect of a new very high-fat, low-carbohydrate,
rotein-permitted diet on myocardial FDG uptake. Com-
ared with the usual fasting approach, this new diet reduced
he maximum standardized myocardial uptake by 50%,
hich might permit FDG-PET imaging of coronary
therosclerosis.
rom the *Division of Cardiovascular Diseases and Internal Medicine, Department of
edicine, and the †Department of Radiology, Mayo Clinic and Mayo Foundation,
ochester, Minnesota. Dr. Gibbons has received a research grant from King
harmaceuticals, which is developing an adenosine agonist for pharmacologic stress
esting, and is a consultant for Molecular Insight Pharmaceuticals. Dr. Williamson is
consultant for GE Medical and for Siemens, and he has received a research grants
rom and is a consultant for Bayer Medical.
Manuscript received August 30, 2008; accepted September 25, 2008.T. A new 320-detector row CT scanner debuted at the
adiologic Society of North America meeting in November
007. Rybicki et al. (3) subjectively evaluated image quality
f coronary CT angiograms performed using this novel
canner in 40 consecutive patients. They reported excellent
mage quality in 89% of coronary segments (517 of 583);
nly a single coronary segment was considered unevaluable
Fig. 1).
Dual-energy CT, which is performed with photons
roduced at 2 different energies, can be used to distinguish
ndividual tissues based on differential X-ray attenuation.
ohnson et al. (4) described very early results in 10 patients
nd demonstrated the ability of this technique to distinguish
ifferent tissues (Fig. 2).
RI. Delfino et al. (5) tested an MRI sequence designed to
easure tissue velocities (similar to Doppler echocardiography)
uring free breathing (navigator-echocardiography–gated
hase-contrast). After phantom validation, they compared
RI velocity measurements in 17 healthy volunteers with
hose in 28 patients with heart failure. Peak longitudinal
nd radial velocities were significantly greater in volunteers
han in patients with heart failure (p  0.05 for all).
iability/Infarction
ET. Evidence for the impact of viability studies on
atient outcomes has generally been limited to observational
tudies. Beanlands et al. (6) reported the results of the
ARR-2 (PET and Recovery Following Revascularization–
hase 2) study, the first large randomized trial using an
DG-PET–guided approach to management of patients
ith coronary disease and severe left ventricular dysfunc-
ion. The primary end point (cardiac death, myocardial
nfarction [MI], or hospital stay for cardiac cause within 1
ear of randomization) was negative; the event rate was 36%
ith standard care without FDG imaging and 30% with
DG imaging (relative risk: 0.82, p  0.16) (Fig. 3). The
bserved event rates were lower than projected in the design
f the trial, reducing its statistical power. Although the
verall result of this first large randomized trial was incon-
lusive, and therefore disappointing, PET-guided therapy
id demonstrate significant benefit in several patient
ubgroups.
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e seen during routine coronary computed tomography
ngiography (CTA), may be of value for the diagnosis of
I. Lessick et al. (7) evaluated 72 patients with acute chest
ain who underwent CTA, and correlated first-pass myo-
ardial hypoenhancement with the clinical diagnosis of MI.
hree patients had to be excluded owing to excessive
rtifact; in the remaining 69 patients, CT demonstrated
oderate accuracy, with 67% sensitivity (33 of 49) and 85%
pecificity (17 of 20) for the presence of infarction by clinical
riteria (Fig. 4).
T-SPECT. Henneman et al. (8) compared the same
echnique—hypoenhancement on early (first-pass) CT im-
ges—with SPECT tetrofosmin imaging in 69 patients
ith previous MI and found that CT detected more infarcts
han SPECT; semiquantitative infarct scores using the 2
echniques correlated closely (r  0.93).
A different technique—delayed myocardial hyperen-
ancement CT—is also promising. Chiou et al. (9) per-
ormed delayed enhancement CT, SPECT thallium, and
obutamine echocardiography on 116 patients with recent
I. The CT imaging identified MI in 97 (96%) patients,
ompared with 88 (87%) patients by SPECT thallium.
sing a pre-defined threshold of 50% segmental involve-
ent by CT, there was modest concordance between CT
nd SPECT thallium (kappa  0.55) and dobutamine echo
kappa  0.50). Sato et al. (10) found that the presence and
ransmural extent of delayed enhancement in 52 patients
ith acute MI predicted poorer recovery of function and
Figure 1 320-Row Coronary CT Angiography
Curved planar reformation of the right coronary artery (RCA) performed using
the new 320-row computed tomography (CT) scanner demonstrates predomi-
nately calcified atherosclerotic changes in the proximal RCA (white arrow).
From Rybicki et al. (3), with permission.ncreased LV dilatation after revascularization.Figure 2 Comprehensive Chest Pain Evaluation
Short-axis computed tomography images in diastole and systole (A, B) demon-
strating a low-attenuation defect and corresponding dyskinesia of the anterior
left ventricular wall (black arrows), characteristic of myocardial infarction.
Curved planar reformation of the left anterior descending coronary artery (C)
shows a patent proximal stent (white arrow) and reperfusion of the distal ves-
sel. From Johnson et al. (4), with permission.
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Year in Cardiac Imaging December 30, 2008/January 6, 2009:54–70T-MRI. Nieman et al. (11) compared both first-pass CT
n  21) and delayed enhancement CT (n  15) with MRI
n patients with recent MI. First-pass perfusion defects were
een in all 21 patients on both CT and MRI but the CT
efect was significantly larger (11  6% of LV myocardium
s. 7 4%). Delayed enhancement was demonstrated on all
5 MRI scans, but on only 11 of 15 CT scans. Three CT
cans could not be evaluated. Contrast-to-noise ratio was
uch better with MRI (p  0.001), suggesting a need for
urther research with CT.
Figure 3 Outcomes With PET-Guided Therapy
Survival free of cardiovascular death, myocardial infarction, or hospital stay for
cardiac cause within 1 year of randomization in the first large randomized trial
of a positron emission tomography (PET)-guided approach to management of
patients with coronary disease and severe left ventricular dysfunction. Although
the event rate was reduced in the PET arm, this difference was not significant
(relative risk: 0.82, p  0.16). From Beanlands et al. (6), with permission.
Figure 4 Myocardial Infarction Assessment by CT
Short-axis post-contrast computed tomography (CT) images demonstrating a
first-pass transmural perfusion defect in the posterolateral left ventricular wall
(black arrows), characteristic of an acute myocardial infarction. From Lessick
et al. (7), with permission.rRI. In the first international, multicenter trial of delayed
nhancement imaging, Kim et al. (12) randomly allocated
82 patients with acute MI and 284 patients with chronic
I to different doses of gadolinium. They found the highest
ensitivity (97%) for their highest dose of contrast (0.3
mol/kg), and the lowest sensitivity (76%) in patients with
cute MI in the lowest tertile of creatine kinase-myocardial
and values, suggesting a lower limit for the detection of MI
y MRI delayed enhancement imaging.
Although the presence of MI can be determined with
elayed enhancement, the severity of the MI seems to be
est measured with MRI-detected microvascular obstruc-
ion. Microvascular obstruction, usually demonstrated as a
entral dark region inside an area of delayed enhancement,
s thought to reflect capillary damage, which restricts con-
rast access (Fig. 5) (13). Several studies have validated
RI-detected microvascular obstruction against coronary
ngiography, MRI perfusion, and pathology (Table 1)
14–18).
RI-SPECT. In contrast, Nagao et al. (19) validated
01-thallium (201-Tl) SPECT and 99m-technetium-
ydroxymethylenediphsphonate (99m-Tc-HMDP) SPECT
sing MRI-detected microvascular obstruction as the external
tandard in 40 patients with reperfused acute MI. Areas with
vidence of infarction by both SPECT radiotracers (namely,
oth decreased 201-Tl and increased 99m-Tc-HMDP) cor-
Figure 5 Example of Microvascular Obstruction
Delayed-enhancement magnetic resonance imaging (MRI) scan, in a plane com-
parable to an echocardiographic parasternal long-axis view, shows a rim of
increased signal in the inferolateral wall (black arrows) surrounding a dark,
nonenhancing core (white arrow). The nonenhancing core represents microvas-
cular obstruction. Modified from Nijeveldt et al. (13), with permission.esponded to microvascular obstruction on MRI.
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PECT. The dramatic increase in cardiac imaging during
he past decade has led to concern over the increased
umulative population exposure to ionizing radiation. Ein-
tein et al. (20) systematically reviewed the recent literature
n this subject and provided a comprehensive review of
adiation principles, terminology, and dosimetry, as well as
uggestions for strategies to minimize radiation exposure
uring SPECT, PET, CT, and coronary angiography.
heir tabulated data show a 10-fold range of estimated
ffective radiation dose for different nuclear cardiology
rocedures (Table 2) (20).
T. A second paper by Einstein et al. (21) reported dose
stimates for individual organs from CTA using Monte
arlo simulations in mathematical phantoms and deter-
ined the lifetime attributable risk of cancer incidence
ssociated with these dose estimates. Lifetime attributable
isk primarily reflected the subsequent risk of lung and
reast cancer and was highest among young women. Ret-
ospective electrocardiography (ECG)-gating with tube
urrent modulation reduced both the estimated effective
ose and lifetime attributable risk by approximately one-
hird (21). As tube current modulation techniques are
efined, further dose reductions are anticipated.
Other studies reported an even greater reduction in
adiation dose using prospective ECG-triggering, a nonhe-
ical “step-and-shoot” technique that does not involve the
cquisition of redundant data and therefore limits mul-
iphase (cine) reconstructions. Earls et al. (22) reported an
3% decrease in radiation dose (from 18.4 to 2.8 mSv)
ompared with retrospective ECG-gating without a de-
alidation Studies of MRI-Detected Microvascular Obstruction
Table 1 Validation Studies of MRI-Detected Microvascular Obs
Author (Ref. #) n Population
Hirsch et al. (14) 27 First acute STEMI with
successful PCI
Applebaum et al. (15) 21 STEMI with successful PCI
Nagao et al. (16) 33 Acute MI with successful PCI
Basso et al. (17) 2 Acute MI, PCI, and in vivo
MRI before death from
cardiogenic shock
Porto et al. (18) 27 First STEMI with PCI
Imyocardial infarction; MOmicrovascular obstruction; MRImagnetic resonance imaging;
hrombolysis In Myocardial Infarction.rease in image quality. Husmann et al. (23) demonstrated
e
Snitial clinical feasibility of prospective ECG-triggering in
1 patients, with an average effective dose of 2.1 mSv.
The American College of Radiology published an impor-
ant white paper on radiation in medicine, with a detailed
ist of recommendations for referring physicians, radiolo-
ists, technologists, and patients (24).
RI. Nephrogenic systemic sclerosis is a systemic disease
nvolving fibrosis of multiple organs, particularly the skin,
hat has been linked to gadolinium exposure in patients with
enal insufficiency (25). There have been numerous reports
ion
Reference Standard Result
Intracoronary Doppler in
infarct-related artery
Early systolic retrograde flow more likely in
patients with MO (p  0.001);
correlation between extent of MO and
diastolic/systolic velocity (r  0.44,
p  0.02), diastolic deceleration time
(r  0.61, p  0.001), diastolic
deceleration rate (r  0.75,
p  0.0001), coronary flow reserve
(r  .044, p  0.001)
TIMI myocardial
perfusion grade
MO associated with abnormal TIMI grade
(90% with grade 0/1/2 vs. 18% with
grade 3, p  0.01)
Resting first-pass
perfusion by MRI
MO associated with lower resting perfusion
in infarct territories
Autopsy and ex vivo MRI Hemorrhagic MI accounts for in vivo MO
Myocardial blush grade,
ST-segment
resolution
MO associated with decreased myocardial
blush (p  0.001); no relation between
ST-segment resolution and MO
percutaneous coronary intervention; STEMI ST-segment elevation myocardial infarction; TIMI 
stimated Effective Radiation Doses of Differentardiac Imaging Proce ures
Table 2 Estimated Effective Radiation Doses of DifferentCardiac Imaging Procedures
Procedure
Estimated Effective
Dose (mSv)
PET
Nitrogen-13 ammonia 2.3
Rubidium-82 12.8
SPECT
Technetium-99m tetrofosmin, rest—stress 8.6
Technetium-99m sestamibi, rest—stress 10.7
Thallium-201, stress—redistribution 16.9
Dual isotope thallium-201 technetium-99m sestamibi 23.7
CT coronary angiography
Females, without ECG-TCM 21
Males, without ECG-TCM 15
Females, with ECG-TCM 14
Males, with ECG-TCM 9
odified from Einstein et al. (20) and Einstein et al. (21), with permission. PET/SPECT estimates
ased on 2007 tissue weighting factors; CT coronary angiography estimates based on 1990 tissue
eighting factors.
CT  computed tomography; ECG  electrocardiography; ECG-TCM  retrospectivetruct
PCIlectrocardiography-gating with tube current modulation; PET  positron emission tomography;
PECT  single-photon emission computed tomography.
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Year in Cardiac Imaging December 30, 2008/January 6, 2009:54–70escribing the development of nephrogenic systemic sclero-
is in small numbers of patients with renal failure exposed to
RI contrast agents. The prevailing theory is that gadolin-
um dissociates from its carrier molecule and accumulates in
he tissue of patients with renal failure because it is not
leared. Singh et al. (26), Swaminathan et al. (27), and
chroeder et al. (28) reported cases in which gadolinium
eposits were detected in the skin and other organs in a total
f 5 patients with nephrogenic systemic sclerosis. The
uropean Society of Urogenital Radiology released guide-
ines regarding the use of gadolinium-containing MRI
ontrast agents (29), suggesting that these agents are con-
raindicated for patients with a glomerular filtration rate
30 ml/min and recommending caution for patients with a
lomerular filtration rate of 30 to 60 ml/min.
oronary Artery Disease
iagnosis. SPECT. Iskandrian et al. (30) reported a multi-
enter, double-blinded trial comparing stress with regade-
oson, a new selective A2A receptor agonist, with stress with
denosine for 784 patients undergoing SPECT; regadeno-
on provided comparable diagnostic information with fewer
ide effects. Ragosta et al. (31) performed fractional flow
eserve (FFR) measurements at the time of coronary an-
iography on 36 selected patients with prior SPECT sesta-
ibi. They reported concordance between coronary angiog-
aphy, FFR, and SPECT in 61 of 88 (69%) diseased vessels.
n the remaining 27 vessels, SPECT underestimated disease
urden compared with FFR.
Kane et al. (32) showed that a hypertensive response to
xercise does not increase the prevalence of abnormal
PECT scans. Prosnitz et al. (33) extended a prospective
tudy of patients receiving radiation for breast cancer and
eported that SPECT perfusion defects were present in a
ajority of patients 3 to 6 years later.
ET. FDG-PET has increasingly been used to study myo-
ardial glucose utilization in a variety of metabolic condi-
ions. Naoumova et al. (34) reported a randomized trial of
6 patients with familial combined hyperlipidemia, in which
ioglitazone improved myocardial blood flow and myocar-
ial glucose utilization compared with placebo.
T. Chung et al. (35) reported the 95% repeatability limits
or CT coronary artery calcification on repeated scans in
,380 subjects in the Multi-Ethnic Study of Atherosclero-
is. The limits varied with body mass index and initial
alcium score. The required change in Agatston score that
ould represent a definite change in the patient (rather than
easurement error) was 68 for an initial score of 100 and
69 for an initial score of 400.
There were multiple new studies comparing CTA withatheterization (Tables 3 and 4) (36–56). Although the po- iential application of CTA for the noninvasive evaluation of
oncalcified “soft” plaque is exciting, technical limitations
emain. In a phantom study, Horiguchi et al. (57) demon-
trated that low heart rates (50 beats/min), coronary enhance-
ent of 250 HU, and plaque area of 50% of the lumen
llowed accurate characterization of “fatty” and “fibrous” plaque
y 64-row CTA.
Iriart et al. (58) compared 16-row CTA to intravascular
ltrasound (IVUS) in 20 patients with acute coronary
yndromes. CTA identified 79% of all noncalcified plaques
68 of 86) and 95% of culprit lesions (19 of 20), but could
ot detect plaque rupture seen by IVUS. Sun et al. (59)
ompared 64-row CTA to IVUS in 26 patients. CTA
orrectly identified 97% of coronary segments containing
oncalcified plaque (86 of 89) and 90% of coronary seg-
ents without any plaque (118 of 131), but the differenti-
tion of individual plaque components was problematic.
Multiple studies showed a clinically significant prevalence
f extracardiac findings on cardiac CT (Table 5) (50,60–
4). New studies on the diagnosis of chest pain in the
mergency department were limited by small numbers of
atients (Table 6) (65–68).
T-SPECT. Van Werkhoven et al. (69) performed CTA in
7 patients with normal SPECT. Eighteen patients (19%)
ad significant coronary artery disease (CAD), but only 4
atients (4%) had left-main or 3-vessel CAD. Sato et al.
70) compared 64-slice CTA and stress thallium SPECT in
04 patients with stable angina and a low body mass index.
he prevalence of ischemia by SPECT was 5% for stenosis
everity 60%, 86% for stenosis severity 80%, and 44%
or stenosis severity 60% to 80%. Lin et al. (71) compared
TA and SPECT in 163 low-intermediate risk patients;
he extent, location, and composition of coronary plaque
redicted abnormal SPECT.
T-PET. Esteves et al. (72) reported that 34 of 84 (40%)
ow-intermediate risk patients in a chest pain unit had no
etectable calcium. None of these patients had abnormal
denosine PET studies. Di Carli et al. (73) reported
imultaneous PET-CT studies on 110 patients with sus-
ected CAD. Almost one-half (47%) of stenoses of 70%
y CTA were not associated with ischemia by PET.
RI. The previous literature on MRI for diagnosis of CAD
as been limited by small sample sizes. Nandalur (74)
erformed a meta-analysis of 37 small studies comparing
54 patients undergoing MRI stress wall-motion imaging
nd 1,516 patients undergoing MRI stress perfusion imag-
ng with coronary angiography. Stress-induced wall-motion
bnormality had a sensitivity of 83% and a specificity of
6%. Perfusion imaging had a sensitivity of 91% and a
pecificity of 81%. However, these favorable data were based
n high-risk populations who underwent cardiac catheter-
zation; data are limited for low-risk patients.
Selected Recent Studies (>50 Patients) Comparing Coronary CTA With Invasive Coronary Angiography
Table 3 Selected Recent Studies (>50 Patients) Comparing Coronary CTA With Invasive Coronary Angiography
Author (Ref. #) Patient Population n
Age
(yrs)
Heart Rate
(beats/min)
Percent
Excluded Scanner
Analysis by Segment
Comment
Sensitivity for
50% Stenosis Specificity PPV NPV
Hamon et al. (36) Meta-analysis (28 studies) 1,292 NR NR 4% 16-row 95 69 79 92 64-row CTA had better specificity and PPV
than 16-row
695 NR NR 2% 64-row 97 90 93 96
Vanhoenacker et al. (37) Meta-analysis (54 studies) 357 61 61 NR 4-row 84 93 NR NR 64-row CTA had better sensitivity than
16-row; 4-row CTA should not be used
704 NR 16-row 83 96 NR NR
363 NR 64-row 93 96 NR NR
Weustink et al. (38) Symptomatic patients with
low, intermediate, or high
probability
100 61  11 68  11 0 DSCT 95 95 75 99 DSCT performs well over a wide range of
patients
Heuschmid et al. (39) Unselected population with
high prevalence of
disease
51 64  10 65  14 19% DSCT 96 87 61 99 High number of excluded segments due
to large number of stented segments
Ropers et al. (40) Low–intermediate probability 100 61 64 0 DSCT 92 97 68 99 DSCT has high diagnostic accuracy, even
at high heart rates
Leber et al. (41) Intermediate probability 90 58  8 73 0 DSCT 90 98 81 99 DSCT has high diagnostic accuracy, even
at high heart rates
Meijboom et al. (46) High, intermediate, and low
probability of CAD
254 NR NR 0 64-row 88 94 54 99 CTA only useful in low and intermediate
probability groups
Pundziute et al. (43) Intermediate–high probability 103 60  10 NR 0 64-row 85 99 90 98 CTA is effective for both females and
males
Bayrak et al. (44) Low–intermediate probability 100 58  10 64-row 88 99 CTA can exclude CAD in patients in sinus
rhythm
Herzog et al. (45) Low probability 55 67 64 0 64-row 82 97 69 99 MDCTA adequate to exclude disease in
patients with low probability
Meijboom et al. (46) ACS 104 59  9 NR 0 64-row 92 91 60 99 CTA can exclude CAD in patients with ACS
Husmann et al. (47) Low, intermediate, and high
probability
88 64  9 63  9 0 64-row 81 96 69 98 Sensitivity and specificity did not vary with
CAD probability; PPV higher, NPV lower
in patients with high likelihood
Pugliese et al. (48) Low–intermediate probability 204 56  10 57  7 26% 4-row 57 91 60 90 Improvements in scanner technology
permit more complete evaluation;
4-row CTA is not adequate
59  12 56  6 0 16-row (1st gen) 90 93 65 99
59  10 57  5 0 16-row (2nd gen) 97 98 87 100
59  11 58  7 0 64-row 99 96 80 100
Hausleiter et al. (49) Intermediate probability 129 62  10 57  7 0 16-row 93 87 46 99 64-row CT superior for detection of CAD
114 64-row 92 92 54 99
ACS  acute coronary syndrome without ST elevation; CAD  coronary artery disease; CT  computed tomography; CTA  computed tomography angiography; DSCT  dual-source computed tomography; gen  generation; MDCTA multidetector computed tomography
angiography; NPV  negative predictive value; NR  not recorded; PPV  positive predictive value.
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Year in Cardiac Imaging December 30, 2008/January 6, 2009:54–70The high spatial resolution of MRI was used to better
efine the pathophysiology of 2 disease states. Lanza et al.
75) applied dobutamine stress MRI to 18 patients with
ardiac syndrome X, who had typical angina, ST-depression
ssociated with angina during a previous stress test, and
ngiographically normal coronary arteries. They reported
erfusion defects in 10 of the 18 (56%) syndrome X patients
ut in none of 10 age-matched volunteers (p  0.004),
uggesting that patients with syndrome X have impairment
f coronary microcirculation (75).
Selvanayagam et al. (76) reported 44 patients who under-
ent MRI before and after complex PCI. Twenty-five
atients (63%) had new delayed enhancement at follow-up,
uggesting myocardial injury during PCI. These damaged
egments also had decreased perfusion reserve on adenosine
tress MRI (Fig. 6).
Ebeling Barbier et al. (77) performed MRI on 248
olunteers older than age 70 years, randomly chosen from a
wedish municipality, to screen for CAD in the general
opulation. Sixty patients (24%) had MI detected by MRI
elayed enhancement imaging; 49 of these patients with MI
ere clinically unrecognized, and 11 had a clinical history of
I. Patients with a history of MI were significantly differ-
nt from both the patients with unrecognized MI and those
ithout MI, with respect to carotid intima media thickness,
-reactive protein level, and Framingham risk score (41).
rognosis. SPECT. The COURAGE (Clinical Outcomes
tilizing Revascularization and Aggressive Drug Evaluation)
rial is the largest randomized trial ever reported in patients
ith chronic CAD. Shaw et al. (78) reported important results
rom the nuclear substudy. Of the 2,287 COURAGE patients,
14 underwent stress myocardial perfusion imaging before
reatment and 6 to 18 months after randomization. The
ercent ischemic myocardium was assessed quantitatively by a
linded core laboratory. At follow-up, the mean reduction in
schemic myocardium was greater with percutaneous coronary
ntervention (PCI) and optimal medical therapy (2.7%) than
ith optimal medical therapy alone (0.5%) (Fig. 7). One-
hird of those treated with PCI (and optimal medical therapy)
ad a 5% reduction in ischemia, compared with 18.9% of
atients treated with optimal medical therapy. This improve-
ent in the reduction of ischemia with percutaneous interven-
ion did not translate into an improvement in patient outcome
n the much larger overall trial.
Cardiovascular disease remains a major cause of mortality in
atients with end-stage renal disease. Hage et al. (79) reported
ll-cause mortality in 3,698 patients with end-stage renal
isease, 60% of whom underwent stress SPECT. Although
atients with abnormal SPECT perfusion had worse out-
omes, the best predictor of death was the ejection fraction
easured by gated SPECT. Nishimura et al. (80) followed up
75 dialysis patients who underwent dual SPECT imaging
sing iodine-123 beta-methyl-iodophenyl-pentadecanoic acid(BMIPP) and thallium. Severely abnormal BMIPP imagesT H C S C C D H M In-
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December 30, 2008/January 6, 2009:54–70 Year in Cardiac Imagingere highly associated with subsequent death (p  0.0001)
ith a hazard ratio of 21.9. These provocative results require
onfirmation.
T. Two large studies assessed the prognostic value of
oronary calcium scoring in different ethnic groups. In 6,722
symptomatic persons, Detrano et al. (81) found that the
oronary calcium score predicted hard cardiac events inde-
endent of standard risk factors in 4 major racial and ethnic
roups. Nasir et al. (82) showed that coronary calcium
cores in 14,812 asymptomatic subjects had incremental
rognostic value compared with the presence of conven-
ional risk factors in all ethnic groups, but the relative risk
atio for higher calcium scores was greater for African
mericans.
Min et al. (83) evaluated a single-center cohort of 1,127
atients who underwent CTA for the evaluation of chest
ain. The presence, distribution, and severity of CAD
xtracoronary Findings on Cardiac CT, Both CTA and Calcification
Table 5 Extracoronary Findings on Cardiac CT, Both CTA and C
Author
(Ref. #) Patients n
Age
(yrs)
Mueller et al.
(60)
Routine
assessment
of CABG
patency
259 64
Burt et al. (1) Healthy patients
screened for
coronary
calcification
459 65
Cademartiri
et al. (50)
CTA for
suspected
CAD
670 NR
Kirsch et al. (62) CTA for
suspected
CAD
100 63 15
Law et al. (63) CTA for
suspected
CAD
295 56
Healthy patients
screened for
coronary
calcification
140 56
Schietinger et al.
(64)
Cardiac CT
before left
atrial ablation
procedure
149 56 11 69
ABG  coronary artery bypass graft surgery; CI  confidence interval; PE  pulmonary embolismdentified by CTA were independent predictors of all-cause mortality. A normal coronary CTA predicted very low
ortality (0.3%) compared with the overall mortality in the
ntire study population (3.5%).
Matsumoto et al. (84) used CTA to assess the prognostic
ignificance of nonobstructive CAD. Acute coronary syn-
romes were more frequent in patients with low-density
oncalcified coronary plaques (1.82%/year) compared with
hose without (0.86%).
T-SPECT. Ramakrishna et al. (85) reported outcomes in
35 patients who underwent both SPECT and CT for
oronary calcification. Both the SPECT summed stress
core and the CT calcium score were independently associ-
ted with mortality, as well as other secondary cardiac end
oints.
Danciu et al. (86) performed CTA on 421 patients with
ntermediate-risk stress SPECT studies. Only 78 (18.5%)
atients were sent to subsequent invasive coronary angiog-
aphy. The remaining 343 (81.5%) patients were managed
es
cation Studies
cardiac Findings
Definition of Major
Findings CommentMajor
20% Requiring
therapeutic
intervention or
further imaging
work-up
9% (n  24) patients
with cardiac
finding; 13%
(n  34) with
noncardiac finding;
2% (n  7) had both
23% Follow-up required Noncontrast CT scans
demonstrate mainly
pulmonary nodules
(18%)
12% Clinical follow-up or
further imaging
work-up required
7% of findings
considered
compulsory for
investigation
11% Definite clinical
importance
requiring
immediate
evaluation or
intervention
Benign findings most
commonly found
after age 70 yrs.
Critical findings
(including PE and
aortic dissection)
found most
frequently from 60
to 69 yrs old
19% Clinical or imaging
follow-up required
Higher numbers of
significant findings
seen with CTA than
on coronary calcium
scans
8%
% 30%–50% Clinical or imaging
follow-up required
High variability in
detection of
incidental findings
between observers
r abbreviations as in Table 3.Studi
alcifi
Extra
Total
20%
41%
79%
67%
NR
NR
%–97
; otheedically with infrequent (2%) invasive coronary angiog-
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Year in Cardiac Imaging December 30, 2008/January 6, 2009:54–70aphy and a single revascularization procedure over the next
5 months.
T-PET. Schenker et al. (87) reported outcomes in 695
ntermediate-risk patients who underwent both CT for
oronary calcification and rubidium PET. There was a
tepwise increase in deaths and MI with increasing calcium
cores in patients with and without ischemia by PET.
RI. The evidence for the prognostic value of MRI contin-
es to expand. Bodi et al. (88) reported that the induction of
all-motion abnormalities (not perfusion abnormalities) on
ipyridamole stress predicted death and nonfatal MI in 420
atients (p  0.002, hazard ratio: 1.15) (Fig. 8). The
uthors did not address the potential mechanism of this
nexpected finding, as dipyridamole is primarily a vasodi-
ator, which is thought to infrequently cause ischemia or
all-motion abnormalities.
Two articles, 1 by Lund et al. (13) and 1 by Nijveldt et al.
89), which employed MRI to predict remodeling after a
rst, acute ST-segment elevation MI, came to different
onclusions about the relative importance of MRI-measured
nfarct size and microvascular obstruction.
In 55 patients, Lund et al. (89) reported that MRI-
easured infarct size was the strongest predictor of remod-
ling (p  0.001, odds ratio: 1.18), defined as a 20% or
reater increase in left ventricular end-diastolic volume
ndex after 8 months (Fig. 9). They also used receiver-
perating characteristic analysis to compare infarct size and
icrovascular obstruction and found that infarct size was
ore predictive.
In contrast, in 53 patients, Nijveldt et al. (13) reported
hat the presence of microvascular obstruction was more
redictive than infarct size of improvement in left ventric-
lar ejection fraction and left ventricular end-systolic vol-
me after 4 months (Fig. 10).
tructure and Function
PECT. The identification of patients who are most likely
o benefit from cardiac resynchronization therapy remains a
hallenge. Trimble et al. (90) described a novel technique to
evelop normalized phase histograms from gated SPECT
mages and showed that multiple histogram indexes differed
etween normal controls and abnormal subjects. Henneman
t al. (91) compared multiple parameters from phase anal-
sis by gated SPECT, with LV dyssynchrony assessed by
chocardiographic tissue Doppler imaging in 75 patients
ith heart failure who were candidates for cardiac resyn-
hronization therapy. Histogram bandwidth and phase
tandard deviation both correlated well with echocardio-
raphic left ventricular dyssynchrony (r  0.89, p  0.001;
nd r  0.80, p  0.001, respectively). A second study by
enneman et al. (92) reported that these 2 parameters
redicted the response to cardiac resynchronization therapy
t 6-month follow-up of 42 patients with severe heartfailure.T
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December 30, 2008/January 6, 2009:54–70 Year in Cardiac ImagingFigure 6 Decreased Perfusion Reserve
Decreased perfusion reserve in a patient with myocardial injury after percutaneous coronary intervention (PCI). On the left (A, B), magnetic resonance imaging (MRI) per-
fusion signal intensity curves in arbitrary units (a.u.) show that in a myocardial segment, perfusion at rest is equivalent before and after PCI (curves, A). After PCI, the
stress hyperemic response is reduced (curves, B). On the right, delayed enhancement MRI images before PCI (top) and after PCI (bottom) show a new, small area of
delayed enhancement in the inferolateral wall (white arrow), indicating myocardial injury. From Selvanayagam et al. (76), with permission. Solid lines  pre-PCI; dashed
lines  post-PCI; circles  pre-PCI; squares  post-PCI. LV  left ventricle.Figure 7 Nuclear Substudy of the COURAGE Trial
In a nuclear substudy of the COURAGE (Clinical Outcomes Utilizing Revascularization Aggressive Drug Evaluation) trial, the change in percent ischemic myocardium
assessed quantitatively by a blinded core laboratory is shown (left) for patients treated with percutaneous coronary intervention and optimal medical therapy and (right)
for patients treated with optimal medical therapy. The mean reduction in ischemic myocardium was 2.7% in the percutaneous coronary intervention and optimal medical
therapy groups, significantly 0.5% seen in the optimal medical therapy group. From Shaw et al. (78), with permission. CI  confidence interval.
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Year in Cardiac Imaging December 30, 2008/January 6, 2009:54–70T. The use of ECG-gated CT for the assessment of
ardiac function remains a popular topic of investigation.
his year marked the first pilot studies describing the use of
ual-source CT for ventricular function. In a small series of
5 patients, Busch et al. (93) reported that CT modestly
verestimated ejection fraction (3.8%) compared with MR
ith wide confidence limits (15% to 22%). Brodoefel et
l. (94) compared dual-source CT and MRI in 20 patients
Figure 8 Stress MRI Predicts Adverse Events
Survival curves adjusted for diabetes mellitus, hypertension, and previous myo-
cardial infarction (MI) show that patients with magnetic resonance imaging
dipyridamole stress-induced wall-motion abnormalities (dotted line) had more
major adverse cardiac events (MACE), defined as cardiac death or nonfatal MI
than patients without them (solid line). From Bodi et al. (88), with permission.
Figure 9 Infarct Size Correlates With Remodeling
Infarct size by delayed enhancement magnetic resonance imaging plotted
against change in left ventricular end-diastolic volume index (LVEDVI) 8 months
after myocardial infarction shows a correlation (r  0.56, p  0.001). Vertical
line shows a cut off of 24% infarct size, which was found to be the best cut off
for predicting a 20% increase in LVEDVI. From Lund et al. (89), with
permission.tnd reported no systematic difference in ejection fraction,
ith much narrower confidence limits (approximately 5%
o 5%).
Several studies have described the use of contrast-
nhanced CT for the detection of left atrial thrombus before
ulmonary vein ablation for atrial fibrillation. Kim et al. (95)
eported that CT had a sensitivity of 93% and a specificity
f 85% for the detection of left atrial appendage thrombus
r severe spontaneous echo contrast by transesophageal
chocardiography in 223 patients; CT detected all cases of
hrombus. Patel et al. (96) reported that CT had a sensi-
ivity of 100% and a specificity of 72% compared with
chocardiography in 72 patients. Shapiro et al. (97) reported
hat CT had a sensitivity of 80% and a specificity of 73%.
ecause CT is frequently done in these patients to define
ulmonary venous anatomy, the detection of thrombus is a
otential added benefit without additional cost.
RI-CT. Multiple studies evaluated valves with cardiac
RI and CT (Table 7) (98–103).
Tissue characterization by MRI could provide a definitive
iagnosis of cardiac amyloidosis. Vogelsberg et al. (104)
tudied 33 patients, 15 of whom had cardiac amyloidosis
onfirmed by myocardial biopsy. A characteristic pattern of
iffuse, endomyocardial delayed enhancement (Fig. 11) was
0% sensitive and 94% specific.
Petersen et al. (105) reported a comprehensive study of
ypertrophy, fibrosis, and hyperemic myocardial blood flow
n 35 patients with hypertrophic cardiomyopathy. Hyper-
mic blood flow was decreased, particularly in the endocar-
ium, with increasing hypertrophy.
tem Cell Therapy
he enormous literature in this emerging field is beyond
Figure 10 MVO and Remodeling
Patients without microvascular obstruction (MVO) have an improvement
(decrease) in end-systolic volume at follow-up (FU) compared with baseline
(Base). Patients with MVO show no improvement. From Nijveldt et al. (13), with
permission.he scope of this article. The fate and function of stem
MRI and CT for the Evaluation of Cardiac Valves
Table 7 MRI and CT for the Evaluation of Cardiac Valves
Author
(Ref. #) Disease n Population
Investigational
Method Reference Standard Result Conclusion
Pouleur et
al. (98)
Aortic stenosis 48 (27 with aortic
stenosis and
21 controls)
Patients scheduled for
surgery
MRI planimetry
(SSFP); 40-
detector-row CT
planimetry
Intraoperative TEE planimetry,
TTE continuity equation
0.1  0.3 cm difference in valve area from
TEE for both CT and MRI; 0.4  0.5 cm
difference in valve area from TTE for both
CT and MRI
MRI and CT give accurate aortic
valve areas
Stork et
al. (99)
Mitral regurgitation 43 Patients scheduled for
surgery
MRI SSFP
regurgitant jet
direction,
prolapse type,
flail leaflets
TEE for jet detection, jet
direction, and atrial
displacement of prolapse;
surgery for malapposition
and flail leaflets with torn
chordae tendineae
95% sens, 94% spec for detecting jets; 94%
sens, 67% spec for detecting any
prolapse. Good concordance for jet
direction (kappa  0.63); 89% sens, 88%
spec for detecting malapposition. Failure
to detect flail leaflet in 6 of 10 patients
MRI comparable to TEE in
detection of prolapse,
regurgitant jet, and jet
direction. MRI inferior to TEE
in depicting torn chordae
tendineae/flail leaflets
Debl et al.
(100)
Aortic regurgitation 45 patients with
MRI only,
15 with cath
Known or suspected
aortic regurgitation
MRI SSFP LV
volumes for
regurgitant
fraction, MRI
SSFP for
regurgitant area
Cath for regurgitant fraction
and semiquantitative
regurgitant severity
2.7  10.9 regurgitant fraction percentage
points difference between cath and MRI;
MRI regurgitant area of 0.28 cm2 had
90% difference in regurgitant fraction 2.7
 10.9% sens, 91% spec to detect
moderately severe or severe regurgitation
MRI regurgitant volumes and
regurgitant valve area are
useful
Feuchnter
et al.
(101)
Aortic regurgitation 81 Consecutive patients
with coronary CTA
and TTE
64-row CT
detected
incomplete
coaptation of
aortic leaflets
TTE grade of aortic
regurgitation
73% sens, 94% spec for detection of any
aortic regurgitation. All false-negative CTs
had “mild” aortic regurgitation by TTE
Coronary CTA can detect
moderate or severe aortic
regurgitation
Alkadhi
et al.
(102)
Aortic regurgitation 30 Patients with known
aortic regurgitation
and cardiac CTA
64-row CT aortic
regurgitant area
planimetry
TTE grade of aortic
regurgitation
Planimetry area 75 mm2 gave 100% sens
and 95% spec to detect severe
regurgitation
Jassal
et al.
(103)
Aortic regurgitation 64 (30 with aortic
regurgitation,
34 controls)
Patients with aortic
regurgitation by TTE
64-row CT lack of
coaptation of
aortic valve
leaflets,
maximum
anatomic aortic
regurgitant
orifice
TTE vena contracta, ratio of
jet to LVOT height, and the
ratio of the jet to LVOT
cross-sectional area
CT 70% sens, 100% spec for identifying any
aortic regurgitation. Anatomic regurgitant
area correlated well with the TTE-derived
vena contracta (r  0.79, p  0.001),
ratio of jet to LVOT height (r  0.79,
p  0.001), and ratio of jet to LVOT
cross-sectional area (r  0.75, p  0.001)
CT is accurate for assessing
aortic regurgitation
Aortic valve area 2 cm2
Cath  cardiac catheterization; LV  left ventricle; LVOT  left ventricular outflow tract; sens  sensitivity; spec  specificity; SSFP  steady-state free precession; TEE  transesophageal echocardiography; TTE  transthoracic echocardiography; other abbreviations as
in Table 3.
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Year in Cardiac Imaging December 30, 2008/January 6, 2009:54–70ells is an unresolved issue. Amsalem et al. (106) and
errovitis et al. (107) showed that the residual MRI
ignal several weeks after injection of iron-labeled stem
ells is in macrophages, not in viable stem cells. Several
ther investigators labeled and imaged stem cells, tar-
eted to the cardiovascular system, using MRI and
uclear methods (Table 8) (106 –109).
ppropriateness/Utilization
oth public and scientific interest in the appropriateness
f cardiac imaging continues to increase. Gibbons et al.
110) reported the first application of the American
Figure 11 Delayed Enhancement in Cardiac Amyloid
Short-axis delayed enhancement magnetic resonance imaging shows diffuse,
subendocardial delayed enhancement, a pattern the authors found to be 80%
sensitive and 94% specific for biopsy-proven cardiac amyloidosis. Modified
from Voglesberg et al. (104), with permission.
n Vivo Stem-Cell–Labeled Cardiovascular Imaging
Table 8 In Vivo Stem-Cell–Labeled Cardiovascular Imaging
Author (Ref. #) Animal Model
Organ for Desired
Cell Localization Cel
Amsalem et al. (106) Rat MI Heart MS
Qiu et al. (108) Mouse with
atherosclerotic diet
Aorta BM
Terrovitis et al. (107) Rat with or without MI Heart CDC
Mani et al. (109) Mouse MI Heart ES-
MC  bone marrow cells; CDC  cardiac-derived stem cell; ES-CPC  embryonic stem cell-derivwollege of Cardiology Foundation/American Society of
uclear Cardiology appropriateness criteria for SPECT
o 284 patients who underwent stress SPECT and 298
atients who underwent stress echocardiography in an
cademic medical center. Fourteen percent of stress
PECT studies and 18% of stress echo studies were
nappropriate (Fig. 12). Askew et al. (111) examined the
alue of screening for CAD with SPECT in 374 asymp-
omatic patients with atrial fibrillation. SPECT had a low
ield, similar to that in matched patients without atrial
brillation, suggesting that the appropriateness criteria
or this indication should be revised.
Gazelle et al. (112) examined the frequency of SPECT,
ET, and gated blood pool imaging during 1 million
pisodes of outpatient care for cardiac disease in a large
ational health plan. Physicians referring patients for imag-
ng to physicians of the same specialty were 3 times more
ikely to perform imaging than were physicians referring
atients to radiologists, after adjustment for patient age and
omorbidity score.
Two distinguished senior cardiologists published com-
entaries on the potential value of SPECT for screening
symptomatic diabetic patients. Diamond et al. (113) ar-
ued that statin treatment without SPECT imaging would
ave the nation 3.2 billion dollars annually. Beller (114)
uggested that a sequential screening strategy utilizing CT
oronary calcium scoring followed by SPECT merits further
valuation.
Merhige et al. (115) compared the frequency of subse-
uent coronary angiography, revascularization, and costs in
,159 patients who underwent PET, and compared them
Tracer Imaging
Number of Cells
Injected Injection Route
Iron (ferumoxide) 0.5-T MRI 2 106 Direct cardiac
injection
Iron (ferridex) 4.7-T MRI 8 106 IV
Iron (ferumoxide) 3-T MRI 5–7.5 105 Direct
myocardial
injection
Iron (ferridex) 9.4-T MRI 5 105 Direct
myocardial
injection
iac precursor; MSC  mesenchymal stem cell; other abbreviations as in Tables 3 and 6.l Type
C
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On a separate, but equally important topic, Cerqueira et
l. (116) and Budoff et al. (117) published new American
ollege of Cardiology Foundation standards for training in
PECT/PET and cardiac CT, respectively.
SPECT
14%
64%
11%
11%
n = 284
Figure 12 Application of SPECT Appropriateness Criteria
The overall classification of 284 stress single-positron emission computed tomogr
according to the American College of Cardiology Foundation/American Society of N
ing. The results for stress SPECT and stress echo were very similar. From Gibbons
ontinued
Table 8 Continued
Timing of Imaging
After Cell Injection
Histological
Confirmation
of Labeled Cells at
Site of Signal
In Vitro Label
Efficiency Determined
In Vitro
Assess
Labele
1, 2, 4 weeks Yes No Y
13–15 weeks Yes No N
2, 7, 14, 21 days Yes Yes Y
1 day, 1 week Yes No Nonclusions
he authors continue to hope that this review will encour-
ge you, the reader, to examine at least some of these articles
n more detail, and to utilize an integrated, multimodality
pproach in the application of imaging to clinical problems.
Table 1
36%
Appropriate
Uncertain
Inappropriate
Unclassifiable
i
i
i
l i i l
64%
9%18%
9%
Stress Echo
n = 298
SPECT) studies and 298 stress echo studies at Mayo Clinic Rochester is shown,
Cardiology appropriateness criteria for stress SPECT myocardial perfusion imag-
(110), with permission.
ity
of
s
In Vitro Quantification
of Tracer Measured
In Vitro Tracer
Concentration
Required for
Signal Detection Comment
No Not reported At 4 weeks iron present
in macrophages, not
transplanted cells
No Not reported Signal change
detectable in aorta
No Not reported Few or no viable stem
cells in cardiac
tissue after 3 weeks.
Residual signal is
from iron-laden
tissue macrophages
after stem cell death
Yes Not reported Used novel MRI
sequence to image
iron as positive
contrast, and not
signal lossI
aphy (
uclear
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